AIインテリジェンスMay 15, 2026AIインテリジェンス
記事
TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results.
The company is developing novel therapies to overcome resistance to cancer immunotherapy.
Data Cube AI 編集部出典: PR Newswire
01
ソース要約
TuHURA Biosciences, an immuno-oncology company, released Q1 2026 financial results. The company is developing novel therapies to overcome resistance to cancer immunotherapy.